Project Details
Description
A Randomized, Double-blind, Placebo-Controlled, Multi-Center Phase 1b Study to Evaluate the Safety, Efficacy and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesala
| Status | Finished |
|---|---|
| Effective start/end date | 7/24/19 → 2/11/21 |
Funding
- ASSEMBLY BIOSCIENCES, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.